webinar register page

Webinar banner
APPs Role in Cancer Survivorship Care — Advanced Practice Provider Lecture
To earn NCPD/CNE CE credit, participants MUST attend using video to view the slides and video components of the presentation.

Deborah K. Mayer, PhD, RN, AOCN, FAAN
Frances Hill Fox Distinguished Professor, School of Nursing
Director, Cancer Survivorship
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

APPs Role in Cancer Survivorship Care

This lecture will provide information to identify current and future cancer survivorship trends, use a framework to analyze survivors’ risks for long-term late effects and identify unmet needs, describe the APPs role in delivering follow-up/survivorship care and list survivorship resources.

Learning Objectives:
• Identify current and future cancer survivorship trends
• Analyze survivors’ long-term and late effects and unmet needs
• Describe the APP role in delivering follow-up care
• List resources for survivorship care

May 19, 2021 04:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Deborah K. Mayer, PhD, RN, AOCN, FAAN
Director, Cancer Survivorship @UNC School of Nursing
Deborah K. Mayer, PhD, RN, AOCN, FAAN is an advanced practice oncology nurse who has over 40 years of cancer nursing practice, education, research, and management experience. She earned a PhD from the University of Utah, her MSN from Yale University, her BSN from Excelsior College, her Nurse Practitioner Certificate from the University of Maryland, and her diploma from Pennsylvania Hospital School of Nursing. Dr. Mayer is past president of the Oncology Nursing Society (ONS), was a member of the National Cancer Institute’s National Cancer Advisory Board (a Presidential appointment) and Board of Scientific Advisors. Dr. Mayer was elected as a fellow of the American Academy of Nursing. She is active in ONS and the American Society of Clinical Oncology (ASCO) and is a Past Chair of the ASCO Survivorship Committee.